Management of SARS-CoV-2 Infection: Key Focus in Macrolides Efficacy for COVID-19
Medicine
[키워드] acute respiratory syndrome
Anti-inflammatory
Atypical
Azithromycin
bacterial specy
bacteriostatic antibiotics
caused
China
coronavirus
COVID-19
decrease
described
drugs
Effectiveness
Efficacy
evaluate
focus
Hydroxychloroquine
IL-8
immunomodulatory effects
immunostimulant
Infectious disease
interferon
Macrolide
macrolides
matrix metalloproteinases
pandemic
Prevent
pro-inflammatory cytokines
Protein
raising
reduce
Respiratory tract infections
SARS-CoV-2
SARS-COV-2 infection
therapy for COVID-19
Treatment
tumor necrosis factor-alpha
virus replication
Wuhan
[DOI] 10.3389/fmed.2021.642313 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.642313 PMC 바로가기 [Article Type] Medicine